Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
Неэффективное купирование приступов эпизодической мигрени связано с впервые возникшей хронической мигренью
2015-01-22
SCID: 54.1/vdusds8t
Discuss with AI
Migraine Treatment Optimization Questionnaireacute treatment efficacychronic migraineepisodic migrainelogistic regression
Figures from the paper
Abstract (AI)
OBJECTIVE: To test the hypothesis that ineffective acute treatment of episodic migraine (EM) is associated with an increased risk for the subsequent onset of chronic migraine (CM). METHODS: In the American Migraine Prevalence and Prevention Study, respondents with EM in 2006 who completed the Migraine Treatment Optimization Questionnaire (mTOQ-4) and provided outcome data in 2007 were eligible for analyses. The mTOQ-4 is a validated questionnaire that assesses treatment efficacy based on 4 aspects of response to acute treatment. Total mTOQ-4 scores were used to define categories of acute treatment response: very poor, poor, moderate, and maximum treatment efficacy. Logistic regression models were used to examine the dichotomous outcome of transition from EM in 2006 to CM in 2007 as a function of mTOQ-4 category, adjusting for covariates. RESULTS: Among 5,681 eligible study respondents with EM in 2006, 3.1% progressed to CM in 2007. Only 1.9% of the group with maximum treatment efficacy developed CM. Rates of new-onset CM increased in the moderate treatment efficacy (2.7%), poor treatment efficacy (4.4%), and very poor treatment efficacy (6.8%) groups. In the fully adjusted model, the very poor treatment efficacy group had a more than 2-fold increased risk of new-onset CM (odds ratio = 2.55, 95% confidence interval 1.42-4.61) compared to the maximum treatment efficacy group. CONCLUSION: Inadequate acute treatment efficacy was associated with an increased risk of new-onset CM over the course of 1 year. Improving acute treatment outcomes might prevent new-onset CM, although reverse causality cannot be excluded.
Key Findings
1
Among 5,681 respondents with episodic migraine, 3.1% progressed to chronic migraine over one year.
2
New-onset chronic migraine rates increased as acute treatment efficacy worsened, from 1.9% with maximum efficacy to 6.8% with very poor efficacy.
3
The findings suggest that improving acute migraine treatment outcomes might help prevent chronic migraine, although reverse causality cannot be excluded.
4
Very poor acute treatment efficacy was associated with a more than twofold increased risk of chronic migraine versus maximum efficacy (OR 2.55, 95% CI 1.42–4.61).
Research Object
episodic migraine patients undergoing acute treatment and their subsequent transition to chronic migraine
Research Subject
the association between acute treatment efficacy and the one-year risk of new-onset chronic migraine
Publication Details
Publication Date
2015-01-22
Journal
Publisher
ISSN
Cited by
323
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by3
Diagnosis and management of migraine in ten steps2021
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice2018
Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study2016